Biggest News Aggregation in the World
📰 Persistent Lyme News

Persistent Lyme News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Persistent Lyme. Real-time updates on events, politics, business and more.

Flightpath Bio Launches via Illumina Accelerator for Largest Clinical Biomarker Study in Lyme Disease

BERKELEY, Calif., Feb 09, 2021 (SEND2PRESS NEWSWIRE) — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD). * Flightpath is le...
United States Matt Tindall Michael Bellas Flightpath Biosciences Inc Flightpath Biosciences Illumina Accelerator

Flightpath Biosciences Launches via Illumina Accelerator to Conduct Largest Clinical Biomarker Study in Lyme Disease

BERKELEY, Calif., Feb 09, 2021 (SEND2PRESS NEWSWIRE) — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD). * Flightpath is le...
United States Matt Tindall Michael Bellas Flightpath Biosciences Inc Flightpath Biosciences Illumina Accelerator

Via Illumina Accelerator, Flightpath Biosciences Launches Largest Clinical Biomarker Study in Lyme Disease

ENewsChannels NEWS: -- Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator's second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD). :: News from eNewsChannels
United States Matt Tindall Michael Bellas Flightpath Biosciences Illumina Accelerator Persistent Lyme Disease

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science